Corbion banner promoting new RTE EU regulations starting July 1 and a free guide for nature-based Listeria control
Home
SCOLR Pharma, Perrigo...

SCOLR Pharma, Perrigo announce agreement to manufacture and market CDT(R) Nutritional Products

24 Oct 2005
Add foodingredientsfirst as a preferred source on Google
Image

First product shipments expected to begin in early 2006.

24/10/05 SCOLR Pharma, Inc. and Perrigo Company have announced that they entered into an agreement whereby Perrigo will manufacture and market certain sustained release nutritional products based on SCOLR Pharma's proprietary CDT(R) drug delivery platform.

Perrigo anticipates the first product shipments will begin in early-2006.

Based in Bellevue, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company leveraging formulation expertise and its patented CDT platform to introduce distinctive and novel OTC products, prescription drugs and dietary supplements. SCOLR Pharma's CDT drug delivery platform provides distinctive products with tangible benefits for the consumer and competitive commercial advantages for licensees.

http://www.biotech-intelligence.com/html/html/ebde1424fc9a6a67931db64c17f14297.html

All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
Add foodingredientsfirst as a preferred source on Google
Save in your AIChatGPTGoogle AIClaudePerplexityGrok
Subscribe to our newsletters
PlatformsFood Ingredients FirstNutrition InsightPackaging InsightsPersonal Care InsightsThe World of Food Ingredients
About usContact usAdvertisingPrivacy statementSitemapArchive
Follow us
Image